Publication | Open Access

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II

Substance AbuseCost-effectiveness AnalysisHealth PolicyHealth EconomicsMedicineCost-effectiveness AnalysesOutcomes ResearchDrug CostsAddiction MedicinePharmacoeconomicsPharmacotherapyCost EffectivenessPublic HealthEconomic EvaluationPharmacologyHealth Services ResearchGood Research Practices